Drew Angerer/Getty Images US drug giant Pfizer just announced that it is buying cancer biotech Array BioPharma for about $11 billion. Pfizer has been betting heavily that new cancer drugs will be key to its future growth. The latest deal marks a shift for the company into two new, important areas: the skin cancer melanoma […]